UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-Dose, Short-Course Levofloxacin for Community-Acquired Pneumonia: A New Treatment Paradigm

Clinical infectious diseases, 2003-09, Vol.37 (6), p.752-760

2003

Volltextzugriff (PDF)

Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with Ceftobiprole

Antimicrobial Agents and Chemotherapy, 2009-08, Vol.53 (8), p.3294-3301

2009

Volltextzugriff (PDF)

Impact of Different Carbapenems and Regimens of Administration on Resistance Emergence for Three Isogenic Pseudomonas aeruginosa Strains with Differing Mechanisms of Resistance

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2638-2645

2010

Volltextzugriff (PDF)

Probability of Target Attainment for Ceftobiprole as Derived from a Population Pharmacokinetic Analysis of 150 Subjects

Antimicrobial Agents and Chemotherapy, 2007-07, Vol.51 (7), p.2378-2387

2007

Volltextzugriff (PDF)

A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis

Urology (Ridgewood, N.J.), 2008, Vol.71 (1), p.17-22

2008

Volltextzugriff (PDF)

Identification and Pretherapy Susceptibility of Pathogens in Patients with Complicated Urinary Tract Infection or Acute Pyelonephritis Enrolled in a Clinical Study in the United States from November 2004 Through April 2006

Clinical therapeutics, 2007-10, Vol.29 (10), p.2215-2221

2007

Volltextzugriff (PDF)

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy

The Journal of clinical investigation, 2003-07, Vol.112 (2), p.275-285

2003

Volltextzugriff (PDF)

A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis

Current medical research and opinion, 2007-11, Vol.23 (11), p.2637-2645

2007

Volltextzugriff (PDF)

Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study

Clinical therapeutics, 2003-02, Vol.25 (2), p.485-506

2003

Volltextzugriff (PDF)

Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study

Urology (Ridgewood, N.J.), 2003-09, Vol.62 (3), p.537-541

2003

Volltextzugriff (PDF)

Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients

Respiratory medicine, 2006-12, Vol.100 (12), p.2129-2136

2006

Volltextzugriff (PDF)

Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis

Current medical research and opinion, 2010-06, Vol.26 (6), p.1433-1441

2010

Volltextzugriff (PDF)

TREATMENT OF CHRONIC BACTERIAL PROSTATITIS WITH LEVOFLOXACIN AND CIPROFLOXACIN LOWERS SERUM PROSTATE SPECIFIC ANTIGEN

The Journal of urology, 2005-07, Vol.174 (1), p.161-164

2005

Volltextzugriff (PDF)

Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens

Current medical research and opinion, 2004-04, Vol.20 (4), p.555-563

2004

Volltextzugriff (PDF)

Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infections

Current medical research and opinion, 2006-10, Vol.22 (10), p.1997-2006

2006

Volltextzugriff (PDF)

Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity

Current medical research and opinion, 2007-01, Vol.23 (1), p.1-7

2007

Volltextzugriff (PDF)

A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia

Clinical therapeutics, 2002-08, Vol.24 (8), p.1292-1308

2002

Volltextzugriff (PDF)

Latest Industry Information on the Safety Profile of Levofloxacin in the US

Chemotherapy (Basel), 2001-01, Vol.47 (Suppl 3), p.32-37

Kahn, James B.

2001

Volltextzugriff (PDF)

Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: A post hoc analysis of data from severely ill patients

Clinical therapeutics, 2006-08, Vol.28 (8), p.1175-1180

2006

Volltextzugriff (PDF)

Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis

Diagnostic microbiology and infectious disease, 2007-01, Vol.57 (1), p.105-107

2007

Volltextzugriff (PDF)

61: Double-Blind, Randomized Comparison of Levofloxacin 750 MG once Daily for 5 Days and Ciprofloxacin Twice Daily for 10 Days in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis

The Journal of urology, 2007-04, Vol.177 (4), p.21-22

2007

Volltextzugriff (PDF)

Quinolone-induced QT interval prolongation: a not-so-unexpected class effect

Journal of antimicrobial chemotherapy, 2000-11, Vol.46 (5), p.847-848

Kahn, J B

2000

Volltextzugriff (PDF)

Oxacillin-lnduced Agranulocytosis

JAMA : the journal of the American Medical Association, 1978-12, Vol.240 (24), p.2632

Kahn, James B.

1978

Volltextzugriff (PDF)

THE IMPORTANCE OF CHLAMYDIA PNEUMONIAE AS A PATHOGEN: THE 1996 CONSENSUS CONFERENCE ON CHLAMYDIA PNEUMONIAE INFECTIONS

Infectious diseases in clinical practice (Baltimore, Md.), 1997-11, Vol.6 Suppl 2 (Supplement 2), p.S28-S31

1997

Volltextzugriff (PDF)

A case of Weil's disease requiring steroid therapy for thrombocytopenia and bleeding

The American journal of tropical medicine and hygiene, 1982-11, Vol.31 (6), p.1213-1215

Kahn, J B

1982

Volltextzugriff (PDF)

1 – 25 von 508

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(421)
Mit Volltextzugriff
(375)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(508)

Erscheinungsjahr

n.n

Thema

Science & Technology
(332)
Life Sciences & Biomedicine
(279)
Humans
(259)
Male
(149)
Female
(138)
Biological And Medical Sciences
(123)
Adult
(104)
Medical Sciences
(103)
Middle Aged
(98)
Aged
(58)
Infectious Diseases
(51)
General & Internal Medicine
(47)
Adolescent
(45)
Human Immunodeficiency Virus
(42)
Hiv
(40)
Medicine, General & Internal
(39)
Risk Factors
(37)
Treatment Outcome
(37)
Public, Environmental & Occupational Health
(33)
Animals
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

High-Dose, Short-Course Levofloxacin for Community-Acquired Pneumonia: A New Treatment Paradigm

Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with Ceftobiprole

Impact of Different Carbapenems and Regimens of Administration on Resistance Emergence for Three Isogenic Pseudomonas aeruginosa Strains with Differing Mechanisms of Resistance

Probability of Target Attainment for Ceftobiprole as Derived from a Population Pharmacokinetic Analysis of 150 Subjects

A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis

Identification and Pretherapy Susceptibility of Pathogens in Patients with Complicated Urinary Tract Infection or Acute Pyelonephritis Enrolled in a Clinical Study in the United States from November 2004 Through April 2006

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy

A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis

Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study

Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study

Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients

Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis

TREATMENT OF CHRONIC BACTERIAL PROSTATITIS WITH LEVOFLOXACIN AND CIPROFLOXACIN LOWERS SERUM PROSTATE SPECIFIC ANTIGEN

Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens

Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infections

Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity

A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia

Latest Industry Information on the Safety Profile of Levofloxacin in the US

Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: A post hoc analysis of data from severely ill patients

Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis

61: Double-Blind, Randomized Comparison of Levofloxacin 750 MG once Daily for 5 Days and Ciprofloxacin Twice Daily for 10 Days in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis

Quinolone-induced QT interval prolongation: a not-so-unexpected class effect

Oxacillin-lnduced Agranulocytosis

THE IMPORTANCE OF CHLAMYDIA PNEUMONIAE AS A PATHOGEN: THE 1996 CONSENSUS CONFERENCE ON CHLAMYDIA PNEUMONIAE INFECTIONS

A case of Weil's disease requiring steroid therapy for thrombocytopenia and bleeding

Suchergebnisse filtern